VANI
Income statement / Annual
Last year (2023), Vivani Medical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vivani Medical, Inc.'s net income was -$25.65 M.
See Vivani Medical, Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.38 M
|
$6.90 M
|
$7.96 M
|
$3.99 M
|
$8.95 M
|
$3.40 M
|
| Cost of Revenue |
$357,000.00 |
$381,000.00 |
$345,000.00 |
$167,000.00 |
$2.15 M |
$4.89 M |
$7.75 M |
$9.35 M |
$4.30 M |
$3.56 M |
| Gross Profit |
-$357,000.00 |
-$381,000.00 |
-$345,000.00 |
-$167,000.00 |
$1.23 M |
$2.01 M |
$211,000.00 |
-$5.36 M |
$4.65 M |
-$160,283.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0.36 |
0.29 |
0.03 |
-1.35 |
0.52 |
-0.05 |
| Research and Development
Expenses |
$16.97 M
|
$14.17 M
|
$11.00 M
|
$6.87 M
|
$16.50 M
|
$10.21 M
|
$7.99 M
|
$5.35 M
|
$3.04 M
|
$5.04 M
|
| General & Administrative
Expenses |
$10.00 M
|
$7.07 M
|
$2.32 M
|
$2.38 M
|
$9.23 M
|
$10.69 M
|
$10.93 M
|
$10.08 M
|
$8.22 M
|
$6.57 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.10 M
|
$11.34 M
|
$9.57 M
|
$8.99 M
|
$8.94 M
|
$6.84 M
|
| Selling, General &
Administrative Expenses |
$10.00 M
|
$7.07 M
|
$2.32 M
|
$2.38 M
|
$15.33 M
|
$26.63 M
|
$23.56 M
|
$21.77 M
|
$20.67 M
|
$13.41 M
|
| Other Expenses |
$0.00 |
$475,000.00 |
-$91,000.00 |
-$36,000.00 |
$3.35 M |
$4.60 M |
$2.64 M |
-$727,000.00 |
-$991,000.00 |
$2.62 M |
| Operating Expenses |
$26.97 M |
$21.24 M |
$13.32 M |
$9.24 M |
$31.82 M |
$36.83 M |
$28.92 M |
$27.85 M |
$24.70 M |
$21.07 M |
| Cost And Expenses |
$26.97 M |
$21.24 M |
$13.32 M |
$9.24 M |
$33.98 M |
$41.72 M |
$36.67 M |
$37.20 M |
$29.00 M |
$24.63 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$16,000.00 |
$362,000.00 |
$86,000.00 |
$93,000.00 |
$31,000.00 |
$2,000.00 |
$9,108.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$29,000.00 |
$7.03 M |
| Depreciation &
Amortization |
$357,000.00
|
$381,000.00
|
$345,000.00
|
$167,000.00
|
$414,000.00
|
$435,000.00
|
$457,000.00
|
$432,000.00
|
$335,000.00
|
$279,179.00
|
| EBITDA |
-$26.61 M
|
-$19.16 M
|
-$12.98 M
|
-$8.89 M
|
-$33.18 M
|
-$34.66 M
|
-$28.06 M
|
-$32.75 M
|
-$19.68 M
|
-$27.89 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
-8.93 |
-4.99 |
-3.55 |
-8.23 |
-2.2 |
-8.21 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
-9.06
|
-5.05
|
-3.6
|
-8.33
|
-2.24
|
-6.25
|
| Total Other
Income/Expenses Net |
$1.31 M
|
$7.35 M
|
$550,000.00
|
-$36,000.00
|
-$3.00 M
|
-$269,000.00
|
$193,000.00
|
$31,000.00
|
$29,000.00
|
-$13.97 M
|
| Income Before Tax |
-$25.65 M |
-$13.89 M |
-$12.77 M |
-$9.28 M |
-$33.59 M |
-$35.09 M |
-$28.52 M |
-$33.18 M |
-$20.02 M |
-$35.20 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
-9.94
|
-5.09
|
-3.58
|
-8.33
|
-2.24
|
-10.36
|
| Income Tax Expense |
$0.00 |
-$7.35 M |
-$641,000.00 |
$147,703.00 |
$362,000.00 |
$86,000.00 |
$93,000.00 |
$31,000.00 |
$58,000.00 |
-$6.93 M |
| Net Income |
-$25.65 M |
-$6.54 M |
-$12.13 M |
-$9.28 M |
-$33.59 M |
-$35.09 M |
-$28.52 M |
-$33.18 M |
-$20.02 M |
-$35.20 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
-9.94 |
-5.09 |
-3.58 |
-8.33 |
-2.24 |
-10.36 |
| EPS |
-0.5 |
-0.17 |
-1.1 |
-1.35 |
-6.85 |
-12.69 |
-12.64 |
-20.13 |
-13.48 |
-10.31 |
| EPS Diluted |
-0.5 |
-0.17 |
-1.1 |
-1.35 |
-6.85 |
-12.69 |
-12.64 |
-20.13 |
-13.48 |
-10.31 |
| Weighted Average Shares
Out |
$50.85 M
|
$38.24 M
|
$11.03 M
|
$6.86 M
|
$4.90 M
|
$2.77 M
|
$2.26 M
|
$1.65 M
|
$1.48 M
|
$3.41 M
|
| Weighted Average Shares
Out Diluted |
$50.85 M
|
$38.24 M
|
$11.03 M
|
$6.86 M
|
$4.90 M
|
$2.77 M
|
$2.26 M
|
$1.65 M
|
$1.48 M
|
$3.41 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
